No Improvement in OS or PFS from Sacituzumab Govitecan Compared with Chemotherapy In Pretreated Patients with Advanced Urothelial Cancer By Ogkologos - March 24, 2025 876 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the TROPiCS-04 study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Belzutifan with Pembrolizumab for Adjuvant Treatment of Renal Cell Carcinoma How Decades of NCI Support Led to Groundbreaking Discoveries: The Story of Immune Checkpoint Inhibitors Adding Belzutifan to Pembrolizumab Prolongs DFS After Nephrectomy in Patients with ccRCC at Increased Risk for Recurrence MOST POPULAR Breast Cancer Survivor Says Mistletoe Injections Have Kept Her Cancer-Free For... December 9, 2019 Oral Cancer Taught Me How Much Words Matter April 21, 2021 New Safety Signal for Use of Ibrutinib in Combination with Rituximab... September 15, 2021 Neoadjuvant Chemotherapy with mFOLFIRINOX Followed by Chemoradiotherapy Improves Survival in Patients... August 14, 2024 Load more HOT NEWS How and When to Wash Your Reusable Cloth Mask and When... Celebrating 20 Years of Cancer.Net: How We’ve Worked to Empower People... Patients With DCIS Reduce Risk Of Recurrence And Death If They... Pancancer Activity of Dabrafenib Plus Trametinib in Patients with BRAFV600E-Mutated Rare...
